Simulations Plus (NASDAQ:SLP) Shares Down 4.2% – Here’s What Happened

Simulations Plus, Inc. (NASDAQ:SLP)’s share price fell 4.2% during trading on Tuesday . The company traded as low as $33.01 and last traded at $32.74. 53,890 shares traded hands during mid-day trading, a decline of 71% from the average session volume of 188,230 shares. The stock had previously closed at $34.16.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on SLP shares. William Blair reiterated an “outperform” rating on shares of Simulations Plus in a report on Wednesday, January 8th. StockNews.com cut Simulations Plus from a “hold” rating to a “sell” rating in a report on Monday. Finally, KeyCorp boosted their price target on shares of Simulations Plus from $32.00 to $40.00 and gave the company an “overweight” rating in a research note on Wednesday. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, five have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, Simulations Plus presently has a consensus rating of “Moderate Buy” and a consensus price target of $50.00.

Simulations Plus Trading Down 1.9 %

The stock has a market capitalization of $647.57 million, a PE ratio of 80.50 and a beta of 1.13. The stock’s fifty day simple moving average is $28.70 and its 200-day simple moving average is $30.08.

Simulations Plus (NASDAQ:SLP) last released its quarterly earnings results on Thursday, April 3rd. The technology company reported $0.31 earnings per share for the quarter, topping the consensus estimate of $0.25 by $0.06. The business had revenue of $22.43 million for the quarter, compared to analysts’ expectations of $21.93 million. Simulations Plus had a net margin of 10.97% and a return on equity of 6.84%. The firm’s revenue for the quarter was up 22.5% compared to the same quarter last year. During the same period in the previous year, the company earned $0.20 earnings per share. As a group, analysts anticipate that Simulations Plus, Inc. will post 1.09 earnings per share for the current fiscal year.

Insider Activity at Simulations Plus

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the business’s stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $33.91, for a total value of $678,200.00. Following the transaction, the director now directly owns 3,402,584 shares in the company, valued at $115,381,623.44. The trade was a 0.58 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 19.40% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Simulations Plus

Institutional investors have recently bought and sold shares of the company. Jones Financial Companies Lllp lifted its position in shares of Simulations Plus by 53.6% during the 4th quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company’s stock valued at $34,000 after buying an additional 427 shares during the last quarter. Johnson Financial Group Inc. purchased a new stake in Simulations Plus in the 4th quarter worth about $39,000. Fifth Third Bancorp lifted its holdings in Simulations Plus by 33.8% during the first quarter. Fifth Third Bancorp now owns 1,485 shares of the technology company’s stock valued at $36,000 after purchasing an additional 375 shares during the last quarter. Tower Research Capital LLC TRC lifted its holdings in Simulations Plus by 42.2% during the fourth quarter. Tower Research Capital LLC TRC now owns 2,575 shares of the technology company’s stock valued at $72,000 after purchasing an additional 764 shares during the last quarter. Finally, AlphaQuest LLC boosted its position in Simulations Plus by 502.9% during the fourth quarter. AlphaQuest LLC now owns 2,689 shares of the technology company’s stock worth $75,000 after purchasing an additional 2,243 shares during the period. Hedge funds and other institutional investors own 78.08% of the company’s stock.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.